Dr. Collins co-authors a commentary in Cell on opportunities for precision medicine in the coming decade
Dr. Collins and All of Us Research Program CEO Josh Denny highlight seven major opportunities for accelerating tailored medicine in order to create a more equitable health landscape. Cell. Online: March 18, 2021
This page last reviewed on